default author photo

Martin R. Stockler

The University of Sydney - NHMRC Clinical Trials Centre

ABN 15 211 513 464

Locked Bag 77

Camperdown, NSW 1450

Australia

SCHOLARLY PAPERS

7

DOWNLOADS

447

TOTAL CITATIONS

0

Scholarly Papers (7)

1.

Cost-Effectiveness of Oral Cannabinoid-Rich THC:CBD Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting

Number of pages: 34 Posted: 22 Jul 2024
The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre and The University of Sydney - NHMRC Clinical Trials Centre
Downloads 135 (547,695)

Abstract:

Loading...

cost-effectiveness, medicinal cannabis, chemotherapy induced nausea and vomiting, reimbursement, cancer, treatment

2.

Adjuvant Chemotherapy Following Chemo-Radiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemo-Radiation Alone: The Randomised Phase 3 OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274)

Number of pages: 33 Posted: 24 Jan 2023
Peter MacCallum Cancer Centre - Department of Medical Oncology, University of Oklahoma - Stephenson Cancer Center, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, University of Melbourne - Sir Peter MacCallum Department of Oncology, The University of Sydney - School of Psychology, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, University of Toronto - NCIC-CCTG, Loyola University of Chicago - Department of Radiation Oncology, University of Utah - Huntsman Cancer Institute, University of Melbourne - Sir Peter MacCallum Department of Oncology, Auckland District Health Board - Auckland City Hospital, University of Oklahoma - Stephenson Cancer Center, University of Alabama at Birmingham, Brown University - Department of Obstetrics and Gynecology, Sir Charles Gairdner Hospital, University of Queensland - Royal Brisbane and Women’s Hospital, Cook County Hospital, St Joseph’s Hospital, University of California, Los Angeles (UCLA), University of Melbourne - Sir Peter MacCallum Department of Oncology, The Royal Women’s Hospital, Peter MacCallum Cancer Centre - Department of Medical Oncology, University of Arizona - HonorHealth Research Institute and The University of Sydney - NHMRC Clinical Trials Centre
Downloads 101 (694,528)

Abstract:

Loading...

Cervical cancer, adjuvant chemotherapy, chemo-radiation, overall survival, toxicity, quality of life

3.

Challenges of Estimating Treatment Effects after a Positive Interim Analysis

Number of pages: 17 Posted: 06 May 2024
The University of Sydney, The University of Sydney, The University of Sydney, University of Adelaide, Monash University, The University of Sydney - NHMRC Clinical Trials Centre and University of Queensland
Downloads 64 (933,592)

Abstract:

Loading...

Interim analysis, randomized clinical trials, overestimation bias, non-proportional hazards

4.

Pembrolizumab and Denosumab in clear-cell renal-cell carcinoma

Number of pages: 28 Posted: 15 Dec 2025
affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, affiliation not provided to SSRN, The University of Western Australia - Fiona Stanley Hospital, affiliation not provided to SSRN, University of Queensland, Border Medical Oncology, Monash Health, affiliation not provided to SSRN, Flinders University, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Macquarie University, The Kinghorn Cancer Centre, Peter MacCallum Cancer Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Monash University and affiliation not provided to SSRN
Downloads 46 (1,145,425)

Abstract:

Loading...

renal cell carcinoma, Immune checkpoint inhibitors, RANKL inhibition, clinical trial, pembrolizumab, denosumab

5.

Excisional Treatment  Comparison For  ISitu  Endocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone Biopsy

Number of pages: 17 Posted: 15 Oct 2020
The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, The University of Sydney - Sydney Medical School, Canterbury Health Laboratories - Department of Anatomical Pathology, University of Notre Dame Australia - Institute for Health Research, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, Westmead Hospital - Department of Gynaecological Oncology, University of Notre Dame Australia - Institute for Health Research, University of Notre Dame Australia - Institute for Health Research, Auckland City Hospital - Department of Gynaecological Oncology, King Edward Memorial Hospital - Department of Gynaecological Oncology, University of Otago - Department of Obstetrics and Gynaecology, Westmead Hospital - Department of Gynaecological Oncology, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, Auckland City Hospital - Department of Gynaecological Oncology, The University of Western Australia, Faculty of Medical and Health Sciences, Division of Obstetrics and Gynaecology, St. John of God Hospital, Subiaco - Department of Gynaecological Oncology, University of Otago - Department of Obstetrics and Gynaecology, King Edward Memorial Hospital - Department of Histopathology, Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit, The University of Sydney - NHMRC Clinical Trials Centre, University of Otago - Department of Obstetrics and Gynaecology, Australia New Zealand Gynaecological Oncology Group, Clinipath Pathology, Osborne Park, Auckland City Hospital - Department of Gynaecological Oncology and Royal Women's Hospital Melbourne - Oncology and Dysplasia Unit
Downloads 38 (1,209,354)

Abstract:

Loading...

Cervical adenocarcinoma in situ, AIS, cold knife cone biopsy, CKC, loop electrosurgical excision procedure, LEEP, LLETZ, cervical glandular dysplasia, excision biopsy cervix

6.

Investigating the Difference in the Effects of [177lu] Lu-Psma-617 on Overall Survival between Therap and Vision Randomized Trials

Number of pages: 17 Posted: 04 Apr 2024
The University of Sydney, The University of Sydney, The University of Sydney, Peter MacCallum Cancer Centre, Royal North Shore Hospital, Monash University, The University of Sydney - NHMRC Clinical Trials Centre and University of Queensland
Downloads 36 (1,249,711)

Abstract:

Loading...

prostate cancer, Lutetium PSMA, Cabazitaxel, Survival, Treatment Crossover

7.

Tools to Help Oncologists Communicate Survival Time(s) in People with Advanced Cancer A Scoping Review

Number of pages: 45 Posted: 18 Apr 2026
The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney - Concord Repatriation General Hospital and The University of Sydney - Concord Repatriation General Hospital
Downloads 27 (1,399,036)

Abstract:

Loading...

prognosis, advanced cancer, doctor-patient communication, tools